These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 6955550

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vivo antigenic modification of tumor cells. II. Distribution of virus in sarcoma-bearing mice.
    Iglehart JD, Ward EC, Huper G, Thiel K, Bolognesi DP.
    J Natl Cancer Inst; 1981 Jul; 67(1):117-22. PubMed ID: 6942182
    [Abstract] [Full Text] [Related]

  • 5. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
    Basombrío MA, Mayer AM, Pasqualini CD.
    Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461
    [Abstract] [Full Text] [Related]

  • 6. Immunotherapy of murine leukemia. VIII. Efficacy of passive serum therapy of Friend leukemia virus-induced disease in immunocompromised mice.
    Genovesi EV, Livnat D, Collins JJ.
    J Natl Cancer Inst; 1983 Feb; 70(2):311-22. PubMed ID: 6337292
    [Abstract] [Full Text] [Related]

  • 7. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens.
    Zbar B, Manohar V, Sugimoto T, Ashley MP, Kato Y, Rappaport P.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4499-507. PubMed ID: 6272979
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Adoptive immunotherapy of newly induced murine sarcomas.
    Shu SY, Rosenberg SA.
    Cancer Res; 1985 Apr; 45(4):1657-62. PubMed ID: 3872168
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Suppression of natural killer cell activity by Friend murine leukemia virus.
    Moody DJ, Specter S, Bendinelli M, Friedman H.
    J Natl Cancer Inst; 1984 Jun; 72(6):1349-56. PubMed ID: 6202923
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Infectivity of Friend murine leukemia virus for hamster cells.
    Ishimoto A.
    J Natl Cancer Inst; 1985 Apr; 74(4):905-8. PubMed ID: 3857383
    [Abstract] [Full Text] [Related]

  • 17. Expression of murine leukemia virus structural antigens on the surface of chemically induced murine sarcomas.
    Grant JP, Bigner DD, Fischinger PJ, Bolognesi DP.
    Proc Natl Acad Sci U S A; 1974 Dec; 71(12):5037-41. PubMed ID: 4373739
    [Abstract] [Full Text] [Related]

  • 18. Identification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicity.
    Sugahara D, Tsuji-Kawahara S, Miyazawa M.
    J Virol; 2004 Jun; 78(12):6322-34. PubMed ID: 15163726
    [Abstract] [Full Text] [Related]

  • 19. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D, Zanovello P, Biasi G, Chieco-Bianchi L.
    J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
    [Abstract] [Full Text] [Related]

  • 20. In vitro growth inhibition of murine leukemia cells by antibody specific for the major envelope glycoprotein (gp71) of Friend leukemia virus.
    Genovesi EV, Collins JJ.
    J Cell Physiol; 1983 Nov; 117(2):215-29. PubMed ID: 6630299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.